• July 23, 2012
    MADISON, N.J.--Pfizer Animal Health (PAH) has launched two educational web sites to communicate advancements in veterinary dermatology and help improve the discussions between veterinarians and pet owners about allergic skin conditions. The two sites—www.mypetitches.com and www.itchcycle.com —bring visitors the latest research and news from the dermatological community and highlight new information about PAH’s portfolio ofmore...
  • February 27, 2012
    MADISON, N.J.--Fostera™ PRRS*, a modified-live vaccine for growing pigs from Pfizer Animal Health, brings a new high standard of innovation to the costly battle against porcine reproductive and respiratory syndrome (PRRS) respiratory disease. Demonstrating its commitment to high standards, Pfizer Animal Health's research and development team made a significant breakthrough. They created unique cell lines that were able to express amore...
  • November 7, 2011
    The benefits of in ovo vaccination are now within the reach of many more hatcheries worldwide, thanks to the development of a new compact device. Embrex* Inovoject* m is a semi-automated in ovo vaccination system from Pfizer Animal Health Global Poultry designed for those hatcheries that do not have a large enough footprint or throughput to justify the installation of a full-size Embrex Inovoject. The new device allows thesemore...
  • December 29, 2010
    MADISON, N.J.--Pfizer Animal Health today announced an agreement to acquire Synbiotics Corporation (Pinksheets SYNB.PK), a privately held, Kansas City-based leader in the development, manufacture and marketing of immunodiagnostic tests for companion and food production animals. Veterinary immunodiagnostics, a methodology using antigen-antibody reaction to detect viruses or bacteria in animals, is a sector growing an estimated 8%more...
  • June 11, 2010
    NEW YORK--Pfizer Animal Health today furthered its commitment to safe food from cattle by announcing a global licensing agreement with Epitopix that will expand access to its conditionally licensed Escherichia Coli Bacterial Extract vaccine* to U.S. cattle producers this fall. “Pfizer Animal Health supports cattle producers’ continuing strides against harmful bacteria, often the most frequent causes of food borne illnesses inmore...
  • February 18, 2010
    NEW YORK--In 2009, Pfizer Animal Health contributed more than $1.3 million to support FFA programs and help fund the American Association of Bovine Practitioners (AABP) Foundation/Pfizer Veterinary Student Scholarships through a unique partnership with veterinarians, animal health suppliers and dealers. Today, Pfizer announces the same program is available for 2010 through March 31. During this time, eligible accounts completing anmore...
  • February 15, 2010
    LAS VEGAS--Pfizer Animal Health today announced that the U.S. Food and Drug Administration (FDA) has approved EXCEDE® Sterile Suspension as the first safe and effective, long-acting antibiotic formulation licensed for horses. EXCEDE Sterile Suspension is the newest addition to Pfizer Animal Health’s extensive portfolio of equine products backed by scientific research and innovation in the field of equine medicine. EXCEDE Sterilemore...
  • February 8, 2010
    TOKYO--Pfizer Animal Health today announced it will begin to expand Japanese veterinary experience with IMPROVAC, Pfizer’s successful pork production technology embraced by pig farmers in other countries for more than 10 years. The Japanese Ministry of Agriculture Forestry and Fishery (JMAFF) has approved IMPROVAC as safe and effective for use by veterinarians in pigs throughout Japan. "In the months ahead, the experience gained withmore...
  • January 14, 2010
    KALAMAZOO, Mich.--A significant milestone in the history of beef genetics occurred today when Pfizer Animal Genetics announced the completion of HD 50K, the beef industry’s first commercially available predictions based on a High- Density panel of more than 50,000 markers. This breakthrough represents significantly greater selection opportunities for owners of black Angus cattle. “Pfizer Animal Genetics is very proud to bring a High-more...
  • January 28, 2009
    DURHAM, N.C.--An ever-growing world population, coupled with increasing feed costs and production pressures, will make demands on the global poultry industry greater than ever in years ahead. Poised to meet those demands is the Poultry Health Division of Pfizer Animal Health (PPH), a hybrid of engineering and poultry animal health technology and innovation that was born via the acquisition of Embrex, Inc. by Pfizer Animal Health in 2007more...